Anne Staples receives National Institutes of Health Trailblazer Award to develop featherweight drug delivery devices
October 04, 2024
October 04, 2024
BLACKSBURG, Virginia, Oct. 4 -- Virginia Tech issued the following news:
In an international study, Type 1 diabetes patients reported the bulkiness of insulin pumps, their interference with activity, embarrassment, injection site pain, and inconvenience to be their top reasons for not adhering to prescribed insulin regimens.
An interdisciplinary team of researchers at Virginia Tech and Georgia Tech is after better solutions for patients with wearable drug delivery devic . . .
In an international study, Type 1 diabetes patients reported the bulkiness of insulin pumps, their interference with activity, embarrassment, injection site pain, and inconvenience to be their top reasons for not adhering to prescribed insulin regimens.
An interdisciplinary team of researchers at Virginia Tech and Georgia Tech is after better solutions for patients with wearable drug delivery devic . . .